The accuracy of the Beck's Depression Inventory Scale (BDI-Visayan) as a screening tool for major depressive disorder in end stage renal disease patients at a tertiary hospital in Mandaue City, Cebu, Philippines.
- Author:
Miguel T. LUCERO IV
1
;
Melanie Gail H. DY
2
;
Frederick P. TAMPUS
3
Author Information
- Publication Type:Journal Article, Original
- MeSH: Human; Depression; Dialysis; Screening
- From: Philippine Journal of Internal Medicine 2025;63(2):114-121
- CountryPhilippines
- Language:English
-
Abstract:
BACKGROUND
End-stage renal disease (ESRD) has been increasing in prevalence in recent years. The true prevalence of depression in hemodialysis patients is still not known. Cross-cultural studies showed prevalence ranging from 20-90%. Dimaano translated the Beck’s Depression Inventory Scale into the Visayan language and used this as a screening tool for depression among hemodialysis patients - and this was the first cross-cultural translation of the Beck’s Depression Inventory Scale to the Visayan language (BDI-Visayan).
GENERAL OBJECTIVEDetermine the accuracy of Beck’s Depression Inventory - Visayan in screening for Major Depressive Disorder (MDD) among Visayan-speaking ESRD patients.
STUDY DESIGNCross-sectional survey
STUDY POPULATION AND SETTINGAdult Visayan-speaking patients, ≥ 18 years old with ESRD, with GFR < 15 ml/min/1.73 m2 and ongoing hemodialysis for at least 3 months at the Chong Hua Hospital Mandaue Renal Unit.
METHODOLOGYThe 73 subjects underwent both the BDI-Visayan and the Structured Clinical Interview for DSM Disorders. Data was gathered to determine the accuracy of the BDI-Visayan in detecting Major Depressive Disorder.
RESULTSOf the 73 subjects, 19.2% were identified with MDD, based on the SCID, while 37.0% were identified as depressed using the BDI-Visayan. Analyzed data showed that the accuracy of BDI-Visayan to detect MDD was 67.75%, with a sensitivity of 57.14%, and specificity of 67.8%.
CONCLUSIONBDI-Visayan had an acceptable accuracy in screening for MDD, however, it may tend to have an overdiagnosis in the ESRD population – emphasizing its role as a screening tool for suspected MDD cases.